Literature DB >> 16024883

Cognitive performance of patients with mesial temporal lobe epilepsy and incidental calcified neurocysticercosis.

V C Terra-Bustamante1, E R Coimbra, K O Rezek, S R Escorsi-Rosset, R Guarnieri, C L Dalmagro, L M Inuzuka, M M Bianchin, L Wichert-Ana, V Alexandre, O M Takayanagui, D Araújo, A C dos Santos, C G Carlotti, R Walz, H J Markowitsch, A C Sakamoto.   

Abstract

OBJECTIVES: Although chronic calcified neurocysticercosis (NCC) has been considered a major cause of symptomatic epilepsy in developing countries, it can also be an incidental pathological finding in epileptic patients from endemic regions. The mechanisms of brain plasticity occurring in patients with NCC during and after the inflammatory process related to the parasite infection, death, degeneration, and calcification within the host brain might be an independent factor for cognitive impairment in patients with NCC and epilepsy. In order to assess this possibility cognitive performance of patients with mesial temporal lobe epilepsy related to hippocampal sclerosis (MTLE-HS) with and without NCC was investigated through structured neuropsychological testing.
METHODS: Cognitive performance of long term MTLE-HS patients with (HS-NCC group, n = 32) and without NCC (HS only, n = 48) was compared. Imbalances between the two groups with respect to clinical, demographic, neuroimaging, and electrophysiological variables were adjusted by linear multiple regression analysis and Bonferroni correction for multiple tests. RESULTS AND
CONCLUSIONS: There were no cognitive performance differences between HS-NCC and HS only patients, leading to the conclusion that chronic calcified NCC per se does not aggravate the cognitive performance of patients with long term MTLE-HS.

Entities:  

Mesh:

Year:  2005        PMID: 16024883      PMCID: PMC1739752          DOI: 10.1136/jnnp.2004.048934

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  22 in total

1.  Time-dependent impairment of inhibitory avoidance retention in rats by posttraining infusion of a mitogen-activated protein kinase kinase inhibitor into cortical and limbic structures.

Authors:  R Walz; R Roesler; J Quevedo; M K Sant'Anna; M Madruga; C Rodrigues; C Gottfried; J H Medina; I Izquierdo
Journal:  Neurobiol Learn Mem       Date:  2000-01       Impact factor: 2.877

Review 2.  Cognitive neuroscience and the study of memory.

Authors:  B Milner; L R Squire; E R Kandel
Journal:  Neuron       Date:  1998-03       Impact factor: 17.173

Review 3.  What's wrong with Bonferroni adjustments.

Authors:  T V Perneger
Journal:  BMJ       Date:  1998-04-18

Review 4.  Epidemiology of the epilepsies.

Authors:  J W Sander; S D Shorvon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

Review 5.  Neurocysticercosis and epilepsy in developing countries.

Authors:  D K Pal; A Carpio; J W Sander
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-02       Impact factor: 10.154

6.  Psychiatric manifestations of neurocysticercosis: a study of 38 patients from a neurology clinic in Brazil.

Authors:  O V Forlenza; A H Filho; J P Nobrega; L dos Ramos Machado; N G de Barros; C H de Camargo; M F da Silva
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

Review 7.  Proposed diagnostic criteria for neurocysticercosis.

Authors:  O H Del Brutto; V Rajshekhar; A C White; V C Tsang; T E Nash; O M Takayanagui; P M Schantz; C A Evans; A Flisser; D Correa; D Botero; J C Allan; E Sarti; A E Gonzalez; R H Gilman; H H García
Journal:  Neurology       Date:  2001-07-24       Impact factor: 9.910

Review 8.  Neuropsychological effects of epilepsy and antiepileptic drugs.

Authors:  P Kwan; M J Brodie
Journal:  Lancet       Date:  2001-01-20       Impact factor: 79.321

9.  Cognitive Performance of Patients with Epilepsy and Calcified Neurocysticercotic Lesions: A Case-Control Study.

Authors:  M C. P. Boppré; P R. Wille; R Guarnieri; K Rezek; C Carqueja; P C. Trevisol-Bittencourt; J C. Walz; M Bianchin; A von Wangenheim; M L. Chaves; R Walz
Journal:  Epilepsy Behav       Date:  2001-12       Impact factor: 2.937

10.  Cysticercosis cerebri. Review of 127 cases.

Authors:  G F McCormick; C S Zee; J Heiden
Journal:  Arch Neurol       Date:  1982-09
View more
  7 in total

1.  The Association Between Neurocysticercosis and Hippocampal Atrophy is Related to Age.

Authors:  Oscar H Del Brutto; Naoum P Issa; Perla Salgado; Victor J Del Brutto; Mauricio Zambrano; Julio Lama; Héctor H García
Journal:  Am J Trop Med Hyg       Date:  2016-11-14       Impact factor: 2.345

2.  The Association between Calcified Neurocysticercosis and Cognitive Performance: A Case-Control Study Nested to a Population-Based Cohort.

Authors:  Oscar H Del Brutto; Robertino M Mera; Mauricio Zambrano; Aldo F Costa; Gustavo C Román
Journal:  Am J Trop Med Hyg       Date:  2019-02       Impact factor: 2.345

3.  Calcified neurocysticercosis associates with hippocampal atrophy: a population-based study.

Authors:  Oscar H Del Brutto; Perla Salgado; Julio Lama; Victor J Del Brutto; Xavier Campos; Mauricio Zambrano; Héctor H García
Journal:  Am J Trop Med Hyg       Date:  2014-10-27       Impact factor: 2.345

4.  Behavioral deficit and decreased GABA receptor functional regulation in the hippocampus of epileptic rats: effect of Bacopa monnieri.

Authors:  Jobin Mathew; Gireesh Gangadharan; Korah P Kuruvilla; C S Paulose
Journal:  Neurochem Res       Date:  2010-09-07       Impact factor: 3.996

5.  Epilepsy in the developing world.

Authors:  Arturo Carpio; W Allen Hauser
Journal:  Curr Neurol Neurosci Rep       Date:  2009-07       Impact factor: 5.081

6.  Epilepsy surgery in context of neurocysticercosis.

Authors:  Gagandeep Singh; Ashwani Kumar Chowdhary
Journal:  Ann Indian Acad Neurol       Date:  2014-03       Impact factor: 1.383

7.  Cognitive and surgical outcome in mesial temporal lobe epilepsy associated with hippocampal sclerosis plus neurocysticercosis: a cohort study.

Authors:  Marino M Bianchin; Tonicarlo R Velasco; Erica R Coimbra; Ana C Gargaro; Sara R Escorsi-Rosset; Lauro Wichert-Ana; Vera C Terra; Veriano Alexandre; David Araujo; Antonio Carlos dos Santos; Regina M F Fernandes; João A Assirati; Carlos G Carlotti; João P Leite; Osvaldo M Takayanagui; Hans J Markowitsch; Américo C Sakamoto
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.